Covid: what is this drug used to fight cancer very effective on seriously ill patients?

It could reduce the risk of death for patients with Covid-19 by 55%.

New progress in the fight against the Covid. Researchers have reported in the New England Journal of Medicine Wednesday that a drug had proven effective in helping patients hospitalized with Covid-19.

it’s about the sabizabulina drug used in the treatment of cancer marketed by the American pharmaceutical company Veru.

The study was carried out on 134 patients receiving oxygen or being intubated. They presented other mortality risk factors such as obesity or high blood pressure.

It reduces lung inflammation

And the results are impressive: more than 45% of people who took a placebo drug died, compared to about 20% of people taking sabizabulin, i.e. a 55% reduction in the overall risk of death.

The drug would act reducing life-threatening lung inflammation on these Covid patients.

Faced with its startling results, Veru, the developer of sabizabulin, asked the US drug authority for a emergency clearance to be able to administer his medicine on a large scale.

Read also :
Covid: Israel launches vaccination of babies over 6 months, with Pfizer and Moderna

Read also :
Covid: according to an American study, the immune system could be responsible for the symptoms of long Covid

Read also :
Covid – 154,615 cases in 24 hours: “I invite the French to wear the mask” launches Élisabeth Borne who excludes a “national measure of obligation”

Read also :
Covid aid scam: a young influencer sentenced to 7 years in prison for having embezzled 7 million euros from the solidarity fund

Read also :
Covid: new waves, new variants… the epidemic threat could last at least another 2 years, experts predict

Read also :
Covid – 7th wave: wearing a mask will once again become compulsory in transport in the Nice metropolis from Monday

Leave a Comment